Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma

被引:64
作者
Kaplan, Lawrence D. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
ACTIVE ANTIRETROVIRAL THERAPY; EXPRESSION PROFILE; HIV-INFECTION; HERPESVIRUS; APOPTOSIS; GROWTH; COMBINATION; BORTEZOMIB; REMISSION; RITUXIMAB;
D O I
10.1182/asheducation-2013.1.103
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Human herpesvirus 8 (HHV8) is a gamma herpesvirus associated with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma, lymphoproliferative diseases that are most commonly observed in immunocompromised individuals. The viral genome expresses genes responsible for inhibition of apoptosis, cell cycle entry, and angiogenesis. Viral homologs of human regulatory genes are expressed, providing stimuli for angiogenesis, B-cell proliferation, and immune evasion. Variations in expression of these factors give rise to the 3 known HHV8-associated malignancies. Identification of these pathogenetic mechanisms has led to exploration of targeted treatment approaches for all 3 of these disorders with success in Kaposi sarcoma and multicentric Castleman disease; primary effusion lymphoma remains a clinical challenge.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 46 条
  • [1] PS-341 or a combination of arsenic trioxide and interferon-α inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells
    Abou-Merhi, R.
    Khoriaty, R.
    Arnoult, D.
    El Hajj, H.
    Dbouk, H.
    Munier, S.
    El-Sabban, M. E.
    Hermine, O.
    Gessain, A.
    de The, H.
    Mahieux, R.
    Bazarbachi, A.
    [J]. LEUKEMIA, 2007, 21 (08) : 1792 - 1801
  • [2] Bhatt S, 2011, BLOOD, V118, P3728
  • [3] Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma
    Bhatt, Shrub
    Ashlock, Brittany M.
    Toomey, Ngoc L.
    Diaz, Luis A.
    Mesri, Enrique A.
    Lossos, Izidore S.
    Ramos, Juan Carlos
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (06) : 2616 - 2628
  • [4] Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS
    Boulanger, E
    Gérard, L
    Gabarre, J
    Molina, JM
    Rapp, C
    Abino, JF
    Cadranel, J
    Chevret, S
    Oksenhendler, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) : 4372 - 4380
  • [5] Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma
    Boulanger, Emmanuelle
    Meignin, Veronique
    Oksenhendler, Eric
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (04) : 559 - 561
  • [6] Brief communication: Rituximab in HIV-associated multicentric Castleman disease
    Bower, Mark
    Powles, Tom
    Williams, Sarah
    Davis, Tom Newsom
    Atkins, Mark
    Montoto, Silvia
    Orkin, Chloe
    Webb, Andy
    Fisher, Martin
    Nelson, Mark
    Gazzard, Brian
    Stebbing, Justin
    Kelleher, Peter
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (12) : 836 - 839
  • [7] Primary effusion lymphoma - A series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis
    Brimo, Fadi
    Michel, Rene P.
    Khetani, Karim
    Auger, Manon
    [J]. CANCER CYTOPATHOLOGY, 2007, 111 (04) : 224 - 233
  • [8] Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas
    Carbone, A
    Gloghini, A
    Larocca, LM
    Capello, D
    Pierconti, F
    Canzonieri, V
    Tirelli, U
    Dalla-Favera, R
    Gaidano, G
    [J]. BLOOD, 2001, 97 (03) : 744 - 751
  • [9] IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA
    CHANG, Y
    CESARMAN, E
    PESSIN, MS
    LEE, F
    CULPEPPER, J
    KNOWLES, DM
    MOORE, PS
    [J]. SCIENCE, 1994, 266 (5192) : 1865 - 1869
  • [10] Primary effusion lymphoma
    Chen, Yi-Bin
    Rahemtullah, Aliyah
    Hochberg, Ephraim
    [J]. ONCOLOGIST, 2007, 12 (05) : 569 - 576